Table 3. Methods and results of cost-of-illness studies for stroke patients, 1990-2012.
Prevalence-based studies | ||||||||
First author/ year of publication/country |
Patients |
Study designb |
Year of cost (Study period) |
Annual indirect cost in millions |
Proportion of total cost represented by indirect cost, %d (Study period) |
|||
Stroke typea |
Age range |
Local currency (Study period) |
2012 USDc (Study period) |
|||||
Heindenreich, 2011, US20 | All types (as a part of CVD) | All | HCA | 2008 (2010∼2030) | 25,600 (2010) e 44,400 (2030) e | 27,299 (2010) e 47,347 (2030) e | 47 (2010) 32 (2030) | |
Brown, 2006, US21 | IS | 45∼64 | HCA, RA | 2005 (2005∼2050) | 1,177,000f (2005∼2050) | 1,383,736f (2005∼2050) | 53 (2005∼2050) | |
Chan, 1998, Canada (Ontario)23 | All types (CI, ICH, SAH, TIA) | Under 75 | HCA | 1994∼95 | 328e | 381 e | 38 | |
Smith, 2012, Ireland27 | All types and TIA | All | HCA, OC | 2007 | 143∼248 g | 176∼305 g | 29–31 | |
Gustavsson, 2011, European countries7 | All types (as a part of brain disorders) | Unclear | Unclear | 2010 | 4,932g, h | N/Aj | 8 | |
Saka, 2009, UK37 | All types | Under 65 | HCA, RA | 2005 | 3,754 | 6,784 | 42 | |
Pugliatti, 2008, Italy28 | All types (as a part of brain disorders) | Unclear | HCA, RA | 2004 | 792 g, h | 1,189 g, h | 23 | |
Leal, 2006, EU39 | All types (as a part of CVD) | All | HCA/FA, OC | 2003 | 13,285 g | 19,508 g | 39 | |
Luengo-Fernandez, 2006, UK38 | All types (as a part of CVD) | All | HCA/FA, OC | 2004 | 3,328 (HCA) 2,770 (FA) | 6,137 (HCA) 5,108 (FA) | 39 (HCA) 35 (FA) | |
Evers, 1997, Netherlands30 | All types | 18∼64 | HCA | 1993 | 566e | 1,012e | 22 | |
Terént, 1994, Sweden36 | All types | Under 65 | HCA | 1991 (1983) | 2,430 e | 379 e | 24 | |
Scott, 1994, New Zealand42 | IS | 15–64 (n=912) | HCA, OC/RA | 1992 | 6∼14 h | 7∼14 h | 6∼9 |
Incidence-based studies | ||||||||
First author/ year of publication/ country |
Patients |
Study designb |
Year of cost (Study period) |
Annual indirect cost in millions |
Per patient indirect cost, local currency (2012 USD)c |
Proportion of total cost represented by indirect cost,%d |
||
Stroke typea |
Age (sample size) i |
Local currency |
2012 USDc | |||||
Wiebers, 1992, US22 | Unruptured intracranial aneurysms, aneurysmal SAH | All (n=10,300/17,250) | lifetime, HCA | Unclear (1979,1984,1989) | 309.8 (unruptured aneurysm), 1,242.5 (SAH) | 507 (unruptured aneurysm), 2033 (SAH)k | N/A | 59 (unruptured aneurysm), 71 (SAH) |
Taylor, 1996, US9 | First SAH, ICH,IS | All (n=N/A) | lifetime, HCA | 1990 | 23,600e | 41,470 e | N/A | 58 |
Navarrete-Navarro, 2007, Spain32 | First ICH survivors | All (n=425) | lifetime, HCA, RA | 2004 | N/A | N/A | 31,108g (54,067) | 67 |
Ghatnekar, 2004, Sweden34 | First all type | Under 65 (n=4357) | lifetime, HCA | 2000 (first 6 months in 1997) | N/A | N/A | 163,694 (male)e 86,586 (female) e (22,243/11,765) | 25 (male) 14 (female) |
Lopez-Bastida, 2012, Spain31 | All type | Under 65 (n=94) | 1 year, HCA, OC | 2004 | N/A | N/A | 12,449 g (21,637) | 71 |
Persson, 2012, Sweden (VästraGötaland county)33 | First ICH, CI, stroke | All (n=3074) | 1 year, HCA, OC | 2008 | 97 | 11 | N/A | 15 |
Dodel, 2010, Germany24 | SAH | Under 65 (n=101) | 1 year, HCA, RA | 2009 (2004∼2005) | N/A | N/A | 17,350 g (22,850) | 45 |
Rossnagel, 2005, Germany25 | All types and TIA | 18∼64 (n=383) | 1 year, HCA | 2002 | N/A | N/A | 2,014e, g (2,960) | 18 |
Weimar, 2003, Germany26 | ICH | All (n=266) | 1 year, HCA | Unclear (Jan. 1998 ∼ Oct. 1999) | N/A | N/A | 5,537 e, g, k (8,053) | 55 |
Zethraeus, 1999, Sweden35 | All types (as a part of CVD) | Under 64 (n=12) | 1 year, HCA | 1994 (1993∼1995) | N/A | N/A | 71,731e (10,229) | N/A |
Gerzeli, 2005, Italy29 | First IS and hemorrhage | Over 18 (n=449) | 6 months, HCA, OC/RA | 1998 | N/A | N/A | 5,026 g (8,691) | 43 |
Cadilhac,2009, Australia40 | First IS and ICH | Unclear (n=4291/27660) | lifetime, FA | 2004 | 12.8 (ICH)h 46.5 (IS) h | 10 (ICH)h 38 (IS) h | N/A | 5 (ICH) 3 (IS) |
Dewey, 2001, Australia41 | First CI, ICH, and unclassified stroke | Under 65 (n=165) | 1 year, FA, OC | 1997 (May 1996 ∼April 1997) | 56 | 56 | N/A | 10 |
Notes:
CVD (cardiovascular disease, includes hypertension, coronary heart disease, heart failure, stroke, and all other cardiovascular disease); ICH (intracerebral hemorrhagic stroke); IS (ischemic stroke); SAH (subarachnoid hemorrhage); TIA (transient ischemic attack); CI (cerebral infarction); N/A (not available).
Estimation approaches for productivity loss: HCA (the human capital approach), and FA (the friction cost approach). Estimation approaches for the time cost of informal caregiving: OC (the opportunity cost approach), and RA (the replacement approach).
Indirect cost in 2012 USD is estimated by using consumer price indices of study countries in the years of cost and in 2012 from the World Bank (http://data.worldbank.org/indicator/FP.CPI.TOTL) and purchasing power parity (PPP) exchange rate in 2012 from OECD website (http://stats.oecd.org/Index.aspx?datasetcode=SNA_TABLE4).
The proportion of total cost represented by indirect cost = (indirect cost/total cost) × 100. Total cost includes both direct and indirect cost.
Cost of informal caregiving is not included in indirect cost. Also, the total cost does not include the cost of informal caregiving.
Costs are accumulated costs during study periods.
Euro is used as a local currency.
The cost of informal caregiving is included in direct cost and is not separable from that cost. In the calculation of the proportion of total cost represented by indirect cost, the cost of informal caregiving is included in the total cost but not in indirect cost.
When the sample size of the indirect cost is different from the total sample size, the sample size for indirect cost is shown.
Because indirect cost of each country was not provided, we cannot estimate indirect cost in 2012 ISD.
We assume that the year of cost is the publication year.